Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Elite provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.

Tsion Abdi, M.D., is a gastroenterologist specializing in scleroderma bowel disease and gastrointestinal motility issues in patients with scleroderma. She also treats patients with heartburn-related conditions and performs colon cancer screenings. Dr. Abdi is an assistant professor of medicine in the gastroenterology and hepatology division. She earned her M.D. from the Georgetown University School of Medicine. She completed her residency at MedStar Georgetown University Medical Center and performed a fellowship in gastroenterology at Yale-New Haven Hospital. Dr. Abdi joined the Johns Hopkins faculty in 2016. Dr. Abdi has received several awards, including the Wesley Oler, M.D., Award for an Outstanding Resident Physician. She is a member of the American Gastroenterological Association, the American College of Gastroenterology and the American Medical Association. Videos Colorectal Cancer Screening and Guidelines Recent News Articles and Media Coverage From Mentor and Mentee to Trusted Colleagues, Inside Tract (Winter, 2020) Tackling the GI Symptoms of Scleroderma, Clinical Connection (Fall, 2017) Lab Website Tsion Abdi Lab The Tsion Abdi Lab performs clinical research on Scleroderma Bowel Disease and Inflammatory Bowel Disease. Selected Publications Abdelaziz DI, Monzur F, Abdi T, Jackson P, Haddad N (2015) Preoperative Localization of Colorectal Tumors with Endoscopic Tattooing for Laparoscopic Surgery. Journal Clinical Trials 6:227. doi:10.4172/2167-0870.1000227. Dr. Abdi is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Gastroparesis, Systemic Sclerosis (SSc), Bowel Incontinence, Endoscopy, and Gastrectomy.

Dr. Kolb is a specialist in Pulmonary and Critical Care Medicine with special focus on pulmonary vascular disease and Critical Care Medicine. He is an expert in the diagnosis and management of all forms of chronic pulmonary hypertension, and has special interests in the chronic thromboembolic pulmonary hypertension, peri-operative and ICU management of pulmonary hypertension. He is an expert in the management of acute pulmonary embolism, leads the Johns Hopkins Pulmonary Embolism Response Team, and provides longitudinal ambulatory follow-up for patients after acute pulmonary embolism. He has extensive experience in the diagnosis and management of all forms of acute respiratory failure and other life-threatening conditions such as shock, gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis and hyperosmolar states, and acute kidney and liver failure. Dr. Kolb is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant.

Melody Chung is a Rheumatologist in Baltimore, Maryland. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Myositis, and Dermatomyositis.

Arash Hassantoufighi is a Rheumatologist in Columbia, Maryland. Dr. Hassantoufighi is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Axial Spondyloarthritis (AxSpA), and Ankylosing Spondylitis. Dr. Hassantoufighi is currently accepting new patients.

Suzan Abdo is a primary care provider, a Geriatrics specialist and a General Practice provider in Columbia, Maryland. Dr. Abdo is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), Hyperlipoproteinemia Type 4, and Defective Apolipoprotein B-100. Dr. Abdo is currently accepting new patients.

Stephen George is a Rheumatologist in Columbia, Maryland. Dr. George is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Fibromyalgia, Mevalonate Kinase Deficiency, Rheumatoid Arthritis (RA), and Chondrocalcinosis 2. Dr. George is currently accepting new patients.

Ikechukwu Mbonu is a Rheumatologist and a Hospital Medicine provider in Columbia, Maryland. Dr. Mbonu is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Cutaneous Lupus Erythematosus (CLE), and Rheumatoid Arthritis (RA). Dr. Mbonu is currently accepting new patients.

Martin Engelhardt is a Cardiologist in Ellicott City,, Maryland. Dr. Engelhardt is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Atrial Fibrillation, Familial Dilated Cardiomyopathy, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Catherine Simpson is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine, pulmonary and critical care medicine, and pulmonary vascular diseases. Dr. Simpson earned her M.D. from the Louisiana State University School of Medicine. She completed her residency at Johns Hopkins, where she also performed a fellowship in pulmonary and critical care medicine and earned her M.H.S. degree from the Johns Hopkins Bloomberg School of Public Health. Dr. Simpson is rated as an Advanced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, and Scleroderma.

Andrea Fava is a Rheumatologist in Baltimore, Maryland. Dr. Fava is rated as an Advanced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc).

Christopher Ish, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Glen Burnie. He also serves as office medical director at the practice. Dr. Ish received his medical degree from the University of Medicine and Dentistry of New Jersey and completed his residency training in internal medicine and pediatrics at University of Maryland Medical Center in Baltimore. He is an instructor of medicine at The Johns Hopkins University School of Medicine in Baltimore. Dr. Ish is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sitosterolemia, and Scleroderma.

Aparna Balasubramanian is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Balasubramanian is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Veno-Occlusive Disease, Emphysema, and Lung Transplant.

Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins. Dr. Lechtzin is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid.

Dr. Visvanathan is a Professor on faculty at Johns Hopkins. She is a practicing medical oncologist and cancer epidemiologist focused on translating discoveries to the clinic and population as a whole. She directs the Clinical Cancer Genetics and Prevention service at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC) and is an active member of the Breast and Ovarian Program and Cancer Prevention and Control Program. Dr. Visvanathan is also Director of the Cancer Epidemiology Track in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. With her research centered on primary and secondary prevention of breast and ovarian cancer, her goal is to reduce the incidence of and mortality from breast cancer globally by conducting impactful studies at the local, national, and international levels. Specifically, she focuses on the identification of atrisk groups, potential biomarkers of risk and prognosis and evaluation of preventive agents across the continuum. She conducts both observational studies and early phase clinical trials. She also teaches and mentors the next generation of clinicians and cancer researchers. Dr. Visvanathan has also served on national committees focused on Breast Cancer Risk Reduction, Breast Cancer Genetics and Cancer Disparities. She has also co-chaired National Guidelines on Breast Cancer Endocrine Prevention. Locally, serving on the Maryland State Cancer Council. Dr. Visvanathan received her medical degree from the University of Sydney in Australia. She subsequently went on to complete training in internal medicine and medical oncology, including a period as chief resident at Royal Prince Alfred Hospital. She then did further training in Medical Oncology at Johns Hopkins and also obtained a master’s degree in clinical/cancer epidemiology at Johns Hopkins Bloomberg School of Public Health. This was followed by a postdoctoral fellow before coming on to faculty in both the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Visvanathan is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Breast Cancer, Ovarian Cancer, Menopause, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Donald Thomas is a Rheumatologist in Greenbelt, Maryland. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, and Osteoporosis. Dr. Thomas is currently accepting new patients.

Gregory Levickas is a primary care provider, practicing in Internal Medicine in Catonsville, Maryland. Dr. Levickas is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Type 2 Diabetes (T2D), Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Levickas is currently accepting new patients.

Jazibeh Qureshi is a Rheumatologist in Baltimore, Maryland. Dr. Qureshi is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are IgG4-Related Disease, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, MAGIC Syndrome, and Light Chain Deposition Disease (LCDD). Dr. Qureshi is currently accepting new patients.